Link to this page
The Biomarker Ontology
Last uploaded:
June 3, 2024
Jump to:
Preferred Name | Trastuzumab | |
Synonyms |
|
|
Definitions |
A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed. |
|
ID |
http://purl.obolibrary.org/obo/OMIT_0001343 |
|
definition |
A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
|
|
definition_source | ||
fromOldVersion |
yes
|
|
imported from | ||
label |
Trastuzumab
|
|
note |
A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
|
|
preferred label |
Trastuzumab
|
|
prefixIRI |
OMIT:0001343
|
|
prefLabel |
Trastuzumab
|
|
textual definition |
A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping